pulmonary cryptococcosis
Conditions
Interventions
Confirmed pulmonary cryptococcosis group:Nil
Clinical diagnosis pulmonary cryptococcus group:NIl
Sponsors
Shanghai Ruijin Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Age >18 years old; 2.First onset, including patients infected outside and inside the hospital; 3.Confirmation or clinical diagnosis of pulmonary cryptococcosis.
Exclusion criteria
Exclusion criteria: 1.HIV patients; 2.Cases with only symptoms of risk factors and/or unexplained fever without typical or new imaging manifestations and serological, microbiological or pathological evidence.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Epidemiological characteristics of pulmonary cryptococcosis;Distribution and common susceptibility factors;Clinical manifestations of patients with pulmonary cryptococcosis;Image characteristic;Laboratory examination ;Treatment outcome; | — |
Secondary
| Measure | Time frame |
|---|---|
| To study the molecular epidemiology of bacterial strains;Screening susceptibility gene loci in patients with cryptococcus pneumoniae by whole exon sequencing;In vitro susceptibility rate and drug resistance rate of pulmonary cryptococcosis to commonly used antifungal drugs;Risk factors for prognosis of pulmonary cryptococcosis;To compare the differences in laboratory examination, imaging, treatment and prognosis among patients with different risk factors (granulocytosis, immunodeficiency but not granulocytosis, non-immunodeficiency but with underlying disease, and patients without underlying disease); | — |
Countries
China
Contacts
Public ContactQu Jieming
Shanghai Ruijin Hospital
Outcome results
None listed